Icentia is proud to introduce an improved version of CardioSTAT which allows for recording durations of up to 14 days. CardioSTAT was launched in 2015 as a 7-day continuous ECG monitor and has quickly become an essential tool across Canada for the detection of heart rhythm problems.
“This extended recording duration opens the door to more accurate and more definitive diagnosis, especially with respect to paroxysmal atrial fibrillation (AF), the most common cardiac heart arrhythmia and a major cause of disabling or deadly ischaemic strokes.” says Icentia’s CEO, Pierre Paquet.
The clinical necessity and cost effectiveness for longer recording duration has been clearly established. Significantly improved rates of detection of atrial fibrillation in stroke and transient ischemic attack patients with multiple-week monitoring have been demonstrated [1,2] and studies strengthen emerging recommendations for prolonged ECG monitoring in secondary stroke prevention .
CardioSTAT is a thin, flexible strip designed to be invisibly worn under clothing on the upper chest. Comfortable both day and night, it can be worn during physical activity and in the shower.
“The development of this new version of CardioSTAT is the result of our collaborative approach with our clients with respect to how we define our products. Physicians know what they need and it’s our role to listen, understand, and provide them with tools that are perfectly adapted to their practice. With this new version, our engineers were not only able to double the recording duration of CardioSTAT, they also reduced the dimension of the electronics by 40%, allowing the recorder to be even more flexible, consequently more comfortable to wear.” says Pierre Paquet.
CardioSTAT was developed by Icentia in collaboration with cardiologists at the renowned Quebec Heart and Lung Institute, a leading Canadian academic medical centre. CardioSTAT is indicated for patients with suspected cardiac arrhythmias requiring continuous cardiac monitoring over several days.